Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T. An
Observed name:
Tae-young An
Institution:
University of Arizona
Observed institutions:
University of Arizona,
Peking University Cancer Hospital
ORCID:
0009-0005-3715-5668
Observed ORCID:
0009-0005-3715-5668
OpenAlex ID:
A5076618543
36P Prevalence, clinical characteristics, and treatment outcomes of patients with BRAF-mutated advanced NSCLC in China: A real-world multi-center study
2023
·
B. Jia
, J. Zhao
, et al.
·
Journal of Thoracic Oncology
·
4
PDF
Negotiating Femininity With Chinese Male Bodies: Discourses of Makeup in Men’s Lifestyle Magazines in Post-2000 China
2026
·
Tae-young An
·
Men and Masculinities
·
1
445PD ASCEND-6: single-arm, open label, multicenter phase 1/2 study of ceritinib in Chinese pts with advanced ALK-rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with crizotinib
2016
·
L. Zhang
, Y. Shi
, et al.
·
Annals of Oncology
·
1
Show more works
View as search
Works count:
3
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type